These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21605160)

  • 1. Mycoplasma pneumoniae infection induces a neutrophil-derived antimicrobial peptide, cathelin-related antimicrobial peptide.
    Tani K; Shimizu T; Kida Y; Kuwano K
    Microbiol Immunol; 2011 Aug; 55(8):582-8. PubMed ID: 21605160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil-Mediated Lung Injury Both via TLR2-Dependent Production of IL-1α and IL-12 p40, and TLR2-Independent CARDS Toxin after Mycoplasma pneumoniae Infection in Mice.
    Tamiya S; Yoshikawa E; Ogura M; Kuroda E; Suzuki K; Yoshioka Y
    Microbiol Spectr; 2021 Dec; 9(3):e0158821. PubMed ID: 34937175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of granulocyte macrophage colony stimulating factor in hospitalized children with Mycoplasma pneumoniae pneumonia.
    Liu Y; Zhang X; Wang Y; Zhu C; Fan M; Dou X; Hao C; Yan Y; Ji W; Gu G; Lou J; Chen Z
    J Infect Chemother; 2018 Oct; 24(10):789-794. PubMed ID: 30007865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathelicidin-related antimicrobial peptide is required for effective lung mucosal immunity in Gram-negative bacterial pneumonia.
    Kovach MA; Ballinger MN; Newstead MW; Zeng X; Bhan U; Yu FS; Moore BB; Gallo RL; Standiford TJ
    J Immunol; 2012 Jul; 189(1):304-11. PubMed ID: 22634613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 20-Mer Peptide Derived from the Lectin Domain of
    Younis US; Chu HW; Kraft M; Ledford JG
    Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32513852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection.
    Wu Q; Martin RJ; Rino JG; Breed R; Torres RM; Chu HW
    Microbes Infect; 2007 Jan; 9(1):78-86. PubMed ID: 17198762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse.
    Gallo RL; Kim KJ; Bernfield M; Kozak CA; Zanetti M; Merluzzi L; Gennaro R
    J Biol Chem; 1997 May; 272(20):13088-93. PubMed ID: 9148921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and distribution of CARDS toxin during Mycoplasma pneumoniae infection in a murine model.
    Kannan TR; Coalson JJ; Cagle M; Musatovova O; Hardy RD; Baseman JB
    J Infect Dis; 2011 Nov; 204(10):1596-604. PubMed ID: 21957154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of newly established mouse strain MPS to Mycoplasma pneumoniae infection.
    Sasaki Y; Ogura A; Nakayama K; Noguchi Y; Matsuno K; Saito M
    Microbiol Immunol; 1991; 35(3):247-52. PubMed ID: 1908041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin G-regulated release of formyl peptide receptor agonists modulate neutrophil effector functions.
    Woloszynek JC; Hu Y; Pham CT
    J Biol Chem; 2012 Oct; 287(41):34101-9. PubMed ID: 22879591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycoplasma pneumoniae extract induces an IL-17-associated inflammatory reaction in murine lung: implication for mycoplasmal pneumonia.
    Kurai D; Nakagaki K; Wada H; Saraya T; Kamiya S; Fujioka Y; Nakata K; Takizawa H; Goto H
    Inflammation; 2013 Apr; 36(2):285-93. PubMed ID: 23001692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation.
    Salvatore CM; Fonseca-Aten M; Katz-Gaynor K; Gomez AM; Mejias A; Somers C; Chavez-Bueno S; McCracken GH; Hardy RD
    Infect Immun; 2007 Jan; 75(1):236-42. PubMed ID: 17074851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-B cell epitope peptides induce protective immunity against Mycoplasma pneumoniae respiratory tract infection in BALB/c mice.
    Chen Y; Wu Y; Qin L; Yu L; Luo H; Li Y; Wang K; Chen L; Zhu C; He J; Zeng Y; Huang L; You X
    Immunobiology; 2021 May; 226(3):152077. PubMed ID: 33831654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant.
    Kurosaka K; Chen Q; Yarovinsky F; Oppenheim JJ; Yang D
    J Immunol; 2005 May; 174(10):6257-65. PubMed ID: 15879124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRAMP deficiency leads to a pro-inflammatory phenotype and impaired phagocytosis after exposure to bacterial meningitis pathogens.
    Kress E; Merres J; Albrecht LJ; Hammerschmidt S; Pufe T; Tauber SC; Brandenburg LO
    Cell Commun Signal; 2017 Sep; 15(1):32. PubMed ID: 28915816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains.
    Techasaensiri C; Tagliabue C; Cagle M; Iranpour P; Katz K; Kannan TR; Coalson JJ; Baseman JB; Hardy RD
    Am J Respir Crit Care Med; 2010 Sep; 182(6):797-804. PubMed ID: 20508214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous murine antimicrobial peptide CRAMP significantly exacerbates Ovalbumin-induced airway inflammation but ameliorates oxazolone-induced intestinal colitis in BALB/c mice.
    Li Y; Chu X; Liu C; Huang W; Yao Y; Xia Y; Sun P; Long Q; Feng X; Li K; Yang X; Bai H; Sun W; Ma Y
    Hum Vaccin Immunother; 2018 Jan; 14(1):146-158. PubMed ID: 29049008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumonia.
    Fonseca-Aten M; Salvatore CM; Mejías A; Ríos AM; Chávez-Bueno S; Katz K; Gómez AM; McCracken GH; Hardy RD
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4128-36. PubMed ID: 16189089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal interleukin-12 therapy inhibits Mycoplasma pneumoniae clearance and sustains airway obstruction in murine pneumonia.
    Salvatore CM; Fonseca-Aten M; Katz-Gaynor K; Gomez AM; Hardy RD
    Infect Immun; 2008 Feb; 76(2):732-8. PubMed ID: 18039833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mpn491, a secreted nuclease of Mycoplasma pneumoniae, plays a critical role in evading killing by neutrophil extracellular traps.
    Yamamoto T; Kida Y; Sakamoto Y; Kuwano K
    Cell Microbiol; 2017 Mar; 19(3):. PubMed ID: 27603754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.